Drug Groups

[ Brite menu | Download htext | Download json | Help ]
Search

1st Level  2nd Level  3rd Level  4th Level  5th Level  6th Level 

 Antibacterial
 Antiviral
 Antifungal
 Antiparasitic
 Antineoplastic
   DG01918  Tyrosine kinase inhibitor
   DG03159  BRAF inhibitor
   DG03137  MEK inhibitor
   DG03138  CDK inhibitor
   DG01597  mTOR inhibitor
   DG03139  PI3K inhibitor
   DG02942  PARP inhibitor
   DG03337  BCL-2 inhibitor
   DG02938  Immune checkpoint inhibitor
   DG01566  Hedgehog signaling inhibitor
   DG03134  Proteasome inhibitor
   DG03133  Histone deacetylase inhibitor
   DG01500  Adenosine deaminase inhibitor
   DG01585  Estrogen receptor antagonist
   DG01591  Androgen receptor antagonist
   DG01596  Aromatase inhibitor
   DG01524  Triazole antineoplastic
   DG01682  Anthracycline antineoplastic
   DG01727  Anthraquinone antineoplastic
   DG01965  Vinca alkaloid antineoplastic
   DG01529  Topoisomerase inhibitor
   DG03328  Isocitrate dehydrogenase inhibitor
   DG03327  Hypoxia-inducible factor-2 alpha inhibitor
   DG03350  Thalidomide derivative
   DG02018  Antimetabolite
   DG01677  Alkylating agent
   DG01679  Platinum compound
 Immunological agent
 Antidiabetic agent
 Hypolipidemic agent
 Cardiovascular agent
 Blood modifier agent
 Neuropsychiatric agent
 Anti-allergic agent
 Anti-inflammatory
 Analgesic
 Hormonal agent
 Vitamin and mineral
 Gastrointestinal agent
 Respiratory system agent
 Musculo-skeletal system agent
 Dermatological agent
 Ophthalmic agent
 Metabolizing enzyme substrate
 Metabolizing enzyme inhibitor
 Metabolizing enzyme inducer
 Transporter substrate
 Transporter inhibitor
 Transporter inducer
 Unclassified

Last updated: June 26, 2026

» Japanese version